These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 1315665)

  • 1. Termination of a clinical trial with no treatment group difference: the Lupus Nephritis Collaborative Study.
    Lachin JM; Lan SP
    Control Clin Trials; 1992 Feb; 13(1):62-79. PubMed ID: 1315665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progression and remission of renal disease in the Lupus Nephritis Collaborative Study. Results of treatment with prednisone and short-term oral cyclophosphamide.
    Levey AS; Lan SP; Corwin HL; Kasinath BS; Lachin J; Neilson EG; Hunsicker LG; Lewis EJ
    Ann Intern Med; 1992 Jan; 116(2):114-23. PubMed ID: 1727614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A controlled trial of plasmapheresis therapy in severe lupus nephritis. The Lupus Nephritis Collaborative Study Group.
    Lewis EJ; Hunsicker LG; Lan SP; Rohde RD; Lachin JM
    N Engl J Med; 1992 May; 326(21):1373-9. PubMed ID: 1569973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasmapheresis does not increase the risk for infection in immunosuppressed patients with severe lupus nephritis. The Lupus Nephritis Collaborative Study Group.
    Pohl MA; Lan SP; Berl T
    Ann Intern Med; 1991 Jun; 114(11):924-9. PubMed ID: 2024858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment protocols of the lupus nephritis collaborative study of plasmapheresis in severe lupus nephritis. The Lupus Nephritis Collaborative Study Group.
    Clough JD; Lewis EJ; Lachin JM
    Prog Clin Biol Res; 1990; 337():301-7. PubMed ID: 2352989
    [No Abstract]   [Full Text] [Related]  

  • 6. Plasmapheresis therapy is ineffective in SLE. Lupus Nephritis Collaborative Study Group.
    Lewis EJ
    J Clin Apher; 1992; 7(3):153. PubMed ID: 1286995
    [No Abstract]   [Full Text] [Related]  

  • 7. [Lupus nephritis with nephrotic syndrome successfully treated with plasmapheresis and cyclophosphamide].
    Obroniecka I; Korsak J; Wańkowicz Z
    Pol Arch Med Wewn; 1994 Mar; 91(3):227-31. PubMed ID: 8029131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lupus nephritis: classification, clinical features, and treatment.
    Weissleder R; Galarza DA; Garza MA
    Rev Invest Clin; 1987; 39(3):263-76. PubMed ID: 3324251
    [No Abstract]   [Full Text] [Related]  

  • 9. Therapy of lupus nephritis. A two-year prospective study.
    Doria A; Piccoli A; Vesco P; Vaccaro E; Marson P; De Silvestro G; Ossi E; Gambari P
    Ann Med Interne (Paris); 1994; 145(5):307-11. PubMed ID: 7985937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective multicentre trial on the short-term effects of plasma exchange versus cytotoxic drugs in steroid-resistant lupus nephritis.
    Derksen RH; Hené RJ; Kallenberg CG; Valentijn RM; Kater L
    Neth J Med; 1988 Oct; 33(3-4):168-77. PubMed ID: 3067098
    [No Abstract]   [Full Text] [Related]  

  • 11. Plasmapheresis for lupus nephritis. Lupus Plasmapheresis Study Group.
    Euler HH; Schroeder JO
    N Engl J Med; 1992 Oct; 327(14):1028; author reply 1029-30. PubMed ID: 1518539
    [No Abstract]   [Full Text] [Related]  

  • 12. Long-term preservation of renal function in patients with lupus nephritis receiving treatment that includes cyclophosphamide versus those treated with prednisone only.
    Steinberg AD; Steinberg SC
    Arthritis Rheum; 1991 Aug; 34(8):945-50. PubMed ID: 1859488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors predictive of outcome in severe lupus nephritis. Lupus Nephritis Collaborative Study Group.
    Korbet SM; Lewis EJ; Schwartz MM; Reichlin M; Evans J; Rohde RD
    Am J Kidney Dis; 2000 May; 35(5):904-14. PubMed ID: 10793026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leflunomide versus cyclophosphamide in the induction treatment of proliferative lupus nephritis in Chinese patients: a randomized trial.
    Zhang M; Qi C; Zha Y; Chen J; Luo P; Wang L; Sun Z; Wan J; Xing C; Wang S; Jiang G; Sun M; Chen Q; Chen J; Li D; Guan T; Ni Z
    Clin Rheumatol; 2019 Mar; 38(3):859-867. PubMed ID: 30426311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive value of renal pathology in diffuse proliferative lupus glomerulonephritis. Lupus Nephritis Collaborative Study Group.
    Schwartz MM; Bernstein J; Hill GS; Holley K; Phillips EA
    Kidney Int; 1989 Nov; 36(5):891-6. PubMed ID: 2615196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasmapheresis for lupus nephritis.
    Wallace DJ
    N Engl J Med; 1992 Oct; 327(14):1029; author reply 1029-30. PubMed ID: 1518541
    [No Abstract]   [Full Text] [Related]  

  • 17. Therapy of proliferative lupus glomerulonephritis: a prospective trial in The Netherlands.
    van den Wall Bake AW; Berden JH; Derksen RH; de Glas-Vos JW; Hagen EC
    Neth J Med; 1994 Dec; 45(6):280-4. PubMed ID: 7838244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Plasmapheresis combined with pharmacology in the treatment of lupus nephritis: a new therapeutic protocol].
    Russo GE; Bonello M; Vitaliano E; Bosco M; Maresca L; De Paola A; Tedaldi M; Bisciglia MF; Bauco B
    Clin Ter; 2000; 151(1):9-13. PubMed ID: 10822875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apheresis in lupus nephritis.
    Mistry-Burchardi N; Schönermarck U; Samtleben W
    Ther Apher; 2001 Jun; 5(3):161-70. PubMed ID: 11467751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasmapheresis for lupus nephritis.
    Sesso R; Klag M
    N Engl J Med; 1992 Oct; 327(14):1029; author reply 1029-30. PubMed ID: 1518540
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.